GSK plc - stock earnings
GSK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 445.9 million USD | 10.3 billion USD |
| 2023Q3 | 1.8 billion USD | 9.9 billion USD |
| 2023Q2 | 2.1 billion USD | 9.1 billion USD |
| 2023Q1 | 1.8 billion USD | 8.6 billion USD |
| 2022Q4 | 1.8 billion USD | 8.9 billion USD |
| 2022Q3 | 866.1 million USD | 8.7 billion USD |
| 2022Q2 | 1.0 billion USD | 8.4 billion USD |
| 2022Q1 | 2.4 billion USD | 12.8 billion USD |
| 2021Q4 | 1.0 billion USD | 12.9 billion USD |
| 2021Q3 | 1.6 billion USD | 12.2 billion USD |
| 2021Q2 | 1.9 billion USD | 11.2 billion USD |
| 2021Q1 | 1.5 billion USD | 10.2 billion USD |
| 2020Q4 | 925.6 million USD | 11.9 billion USD |
| 2020Q3 | 1.6 billion USD | 11.2 billion USD |
| 2020Q2 | 2.8 billion USD | 9.4 billion USD |
| 2020Q1 | 1.9 billion USD | 11.2 billion USD |
| 2019Q4 | 1.7 billion USD | 11.7 billion USD |
| 2019Q3 | 1.9 billion USD | 11.6 billion USD |
| 2019Q2 | 1.2 billion USD | 9.9 billion USD |
| 2019Q1 | 1.1 billion USD | 10.0 billion USD |
| 2018Q4 | 1.5 billion USD | 10.4 billion USD |
| 2018Q3 | 1.9 billion USD | 10.6 billion USD |
| 2018Q2 | 576.6 million USD | 9.6 billion USD |
| 2018Q1 | 770.3 million USD | 10.1 billion USD |
| 2017Q4 | -734.0 million USD | 10.3 billion USD |
| 2017Q3 | 1.6 billion USD | 10.5 billion USD |
| 2017Q2 | -234.3 million USD | 9.5 billion USD |
| 2017Q1 | 1.3 billion USD | 9.2 billion USD |
| 2016Q4 | 317.2 million USD | 9.4 billion USD |
| 2016Q3 | 1.0 billion USD | 9.8 billion USD |
| 2016Q2 | -585.9 million USD | 8.8 billion USD |
| 2016Q1 | 405.4 million USD | 9.0 billion USD |
| 2015Q4 | -524.6 million USD | 9.3 billion USD |
| 2015Q3 | 815.7 million USD | 9.3 billion USD |
| 2015Q2 | 234.5 million USD | 9.3 billion USD |
| 2015Q1 | 12.0 billion USD | 8.3 billion USD |
| 2014Q4 | 1.6 billion USD | 9.6 billion USD |
| 2014Q3 | 651.4 million USD | 9.2 billion USD |
| 2014Q2 | 1.1 billion USD | 9.5 billion USD |
| 2014Q1 | 1.1 billion USD | 9.3 billion USD |
| 2013Q4 | 4.1 billion USD | 11.4 billion USD |
| 2013Q3 | 1.6 billion USD | 10.5 billion USD |
| 2013Q2 | 1.6 billion USD | 10.1 billion USD |
| 2013Q1 | 1.5 billion USD | 9.8 billion USD |
| 2012Q4 | 1.4 billion USD | 11.0 billion USD |
| 2012Q3 | 1.8 billion USD | 10.6 billion USD |
| 2012Q2 | 1.9 billion USD | 10.0 billion USD |
| 2012Q1 | 2.1 billion USD | 10.6 billion USD |
| 2011Q4 | 1.9 billion USD | 10.8 billion USD |
| 2011Q3 | 2.2 billion USD | 11.1 billion USD |
| 2011Q2 | 1.8 billion USD | 10.8 billion USD |
| 2011Q1 | 2.5 billion USD | 10.6 billion USD |
| 2010Q4 | -1.1 billion USD | 11.1 billion USD |
| 2010Q3 | 2.0 billion USD | 10.8 billion USD |
| 2010Q2 | -454.4 million USD | 10.5 billion USD |
| 2010Q1 | 2.0 billion USD | 11.2 billion USD |
| 2009Q4 | 2.6 billion USD | 13.1 billion USD |
| 2009Q3 | 2.1 billion USD | 10.8 billion USD |
| 2009Q2 | 2.4 billion USD | 11.1 billion USD |
| 2009Q1 | 1.6 billion USD | 9.7 billion USD |
| 2008Q4 | 1.5 billion USD | 10.1 billion USD |
| 2008Q3 | 1.9 billion USD | 10.5 billion USD |
| 2008Q2 | 2.6 billion USD | 11.7 billion USD |
| 2008Q1 | 2.6 billion USD | 11.3 billion USD |
| 2007Q4 | 2.1 billion USD | 11.9 billion USD |
| 2007Q3 | 2.7 billion USD | 11.2 billion USD |
| 2007Q2 | 2.7 billion USD | 11.4 billion USD |
| 2007Q1 | 3.0 billion USD | 11.0 billion USD |
| 2006Q4 | 2.3 billion USD | 11.7 billion USD |
| 2006Q3 | 2.6 billion USD | 10.6 billion USD |
| 2006Q2 | 2.4 billion USD | 10.8 billion USD |
| 2006Q1 | 2.6 billion USD | 10.1 billion USD |
| 2005Q4 | 1.9 billion USD | 10.2 billion USD |
| 2005Q3 | 2.1 billion USD | 9.7 billion USD |
| 2005Q2 | 2.1 billion USD | 9.4 billion USD |
| 2005Q1 | 2.3 billion USD | 9.5 billion USD |
| 2004Q4 | 2.3 billion USD | 10.8 billion USD |
| 2004Q3 | 1.8 billion USD | 8.9 billion USD |
| 2004Q2 | 2.0 billion USD | 9.1 billion USD |
| 2004Q1 | 1.9 billion USD | 9.0 billion USD |
| 2003Q4 | 1.4 billion USD | 9.6 billion USD |
| 2003Q3 | 1.9 billion USD | 9.1 billion USD |
| 2003Q2 | 2.2 billion USD | 8.7 billion USD |
| 2003Q1 | 1.9 billion USD | 8.3 billion USD |
| 2002Q4 | 1.5 billion USD | 9.1 billion USD |
| 2002Q3 | 1.2 billion USD | 7.9 billion USD |
| 2002Q2 | 1.8 billion USD | 8.4 billion USD |
| 2002Q1 | 1.5 billion USD | 7.3 billion USD |
| 2001Q4 | 1.4 billion USD | 8.2 billion USD |
| 2001Q3 | 558.0 million USD | 7.4 billion USD |
| 2001Q2 | 1.5 billion USD | 7.2 billion USD |
| 2001Q1 | 1.0 billion USD | 6.8 billion USD |
| 2000Q4 | 2.6 billion USD | 7.5 billion USD |
| 2000Q3 | 1.1 billion USD | 6.5 billion USD |
| 2000Q2 | 1.3 billion USD | 6.9 billion USD |
| 2000Q1 | 1.3 billion USD | 6.5 billion USD |
| 1999Q4 | 742.0 million USD | 3.7 billion USD |
| 1999Q3 | 583.8 million USD | 2.9 billion USD |
| 1999Q2 | 593.7 million USD | 2.6 billion USD |
| 1999Q1 | 581.4 million USD | 2.6 billion USD |
| 1998Q4 | 643.7 million USD | 2.6 billion USD |
| 1998Q3 | 641.8 million USD | 2.6 billion USD |
| 1998Q2 | 526.2 million USD | 2.5 billion USD |
| 1998Q1 | 526.1 million USD | 2.5 billion USD |
| 1997Q4 | 483.9 million USD | 2.3 billion USD |
| 1997Q3 | 531.9 million USD | 2.5 billion USD |
| 1997Q2 | 651.4 million USD | 2.6 billion USD |
| 1997Q1 | 661.9 million USD | 2.6 billion USD |
| 1996Q4 | 1.1 billion USD | 4.3 billion USD |
| 1996Q3 | 148.5 million USD | 3.2 billion USD |
| 1996Q2 | 663.6 million USD | 2.7 billion USD |
| 1996Q1 | 675.0 million USD | 2.7 billion USD |
| 1995Q3 | 332.8 million USD | 2.1 billion USD |
| 1995Q2 | 344.3 million USD | 2.1 billion USD |
| 1995Q1 | 326.3 million USD | 2.0 billion USD |
| 1994Q4 | 337.0 million USD | 2.1 billion USD |
| 1994Q3 | 333.5 million USD | 2.1 billion USD |
| 1994Q2 | 338.0 million USD | 1.7 billion USD |
| 1994Q1 | 403.6 million USD | 1.9 billion USD |
| 1993Q4 | 459.2 million USD | 1.8 billion USD |
| 1993Q3 | 449.9 million USD | 1.8 billion USD |
| 1993Q2 | 325.1 million USD | 1.4 billion USD |
| 1993Q1 | 454.1 million USD | 1.9 billion USD |
| 1992Q4 | 373.1 million USD | 1.5 billion USD |
| 1992Q3 | 318.1 million USD | 1.2 billion USD |
| 1992Q2 | 236.4 million USD | 937.3 million USD |
| 1992Q1 | 359.6 million USD | 1.4 billion USD |
| 1991Q4 | 334.5 million USD | 1.3 billion USD |
| 1991Q3 | 357.0 million USD | 1.4 billion USD |
| 1991Q2 | ? USD | 1.3 billion USD |
| 1991Q1 | ? USD | 1.0 billion USD |
| 1990Q4 | ? USD | 910.3 million USD |
| 1990Q3 | ? USD | 936.1 million USD |
| 1990Q2 | ? USD | 1.2 billion USD |
| 1990Q1 | ? USD | 998.3 million USD |
| 1989Q4 | ? USD | 958.3 million USD |
| 1989Q3 | ? USD | 946.9 million USD |
| 1989Q2 | ? USD | 1.0 billion USD |
| 1989Q1 | ? USD | 740.7 million USD |
| 1988Q4 | ? USD | 715.6 million USD |
| 1988Q3 | ? USD | 764.5 million USD |
| 1988Q2 | ? USD | 821.1 million USD |
| 1988Q1 | ? USD | 611.7 million USD |
| 1987Q4 | ? USD | 590.1 million USD |
| 1987Q3 | ? USD | 678.7 million USD |
| 1987Q2 | ? USD | 587.7 million USD |
| 1987Q1 | ? USD | 590.3 million USD |
| 1986Q4 | ? USD | 563.9 million USD |
| 1986Q3 | ? USD | 575.2 million USD |
| 1986Q2 | ? USD | 383.7 million USD |
| 1986Q1 | ? USD | 478.5 million USD |
| 1985Q4 | ? USD | 486.1 million USD |
| 1985Q3 | ? USD | 499.7 million USD |
GSK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 6.3 billion USD | 38.6 billion USD |
| 2022 | 6.0 billion USD | 35.5 billion USD |
| 2021 | 5.9 billion USD | 46.1 billion USD |
| 2020 | 7.9 billion USD | 46.6 billion USD |
| 2019 | 6.1 billion USD | 44.3 billion USD |
| 2018 | 4.6 billion USD | 39.1 billion USD |
| 2017 | 2.1 billion USD | 40.6 billion USD |
| 2016 | 1.1 billion USD | 34.4 billion USD |
| 2015 | 12.5 billion USD | 35.5 billion USD |
| 2014 | 4.3 billion USD | 35.8 billion USD |
| 2013 | 9.0 billion USD | 43.7 billion USD |
| 2012 | 7.4 billion USD | 42.9 billion USD |
| 2011 | 8.1 billion USD | 42.2 billion USD |
| 2010 | 2.5 billion USD | 43.8 billion USD |
| 2009 | 8.9 billion USD | 45.9 billion USD |
| 2008 | 6.9 billion USD | 35.6 billion USD |
| 2007 | 10.4 billion USD | 45.1 billion USD |
| 2006 | 10.6 billion USD | 45.5 billion USD |
| 2005 | 8.1 billion USD | 37.3 billion USD |
| 2004 | 7.5 billion USD | 38.4 billion USD |
| 2003 | 8.0 billion USD | 38.4 billion USD |
| 2002 | 6.3 billion USD | 34.1 billion USD |
| 2001 | 4.5 billion USD | 29.6 billion USD |
| 2000 | 6.2 billion USD | 27.0 billion USD |
| 1999 | 2.9 billion USD | 13.7 billion USD |
| 1998 | 2.3 billion USD | 10.2 billion USD |
| 1997 | 2.4 billion USD | 10.2 billion USD |
| 1996 | 2.5 billion USD | 10.6 billion USD |
| 1995 | 1.9 billion USD | 13.4 billion USD |
| 1994 | 1.3 billion USD | 8.2 billion USD |
| 1993 | 1.7 billion USD | 7.2 billion USD |
| 1992 | 1.5 billion USD | 6.3 billion USD |
| 1991 | 1.3 billion USD | 5.2 billion USD |
| 1990 | 1.1 billion USD | 4.3 billion USD |
| 1989 | 1.0 billion USD | 4.0 billion USD |
| 1988 | 875.9 million USD | 3.3 billion USD |
| 1987 | 739.7 million USD | 2.6 billion USD |
| 1986 | 649.3 million USD | 2.2 billion USD |
| 1985 | 509.2 million USD | 1.8 billion USD |
GSK
Price: $43.50
52 week price:
Dividend Yield: 0.01%
5-year range yield:
Forward Dividend Yield: 3.73%
Payout Ratio: 54.15%
Payout Ratio Range:
Dividend Per Share: 1.62 USD
Earnings Per Share: 2.73 USD
P/E Ratio: 13.80
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 3.7 million
Ebitda: 2.0 billionMarket Capitalization: 88.7 billion
Average Dividend Frequency: 3
Years Paying Dividends: 41
DGR3: -10.18%
DGR5: -7.21%
DGR10: -3.71%
DGR20: 1.60%